The current valuation score of Vanda Pharmaceuticals Inc is 7.66, ranking 210 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.43, which is -7468.91% below the recent high of 105.42 and -5239.70% above the recent low of -76.39.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.